ホーム ＞ 書籍詳細ページ
Local and Systemic Management of Primary Breast Cancers
B5変並製・
ISBN: 9784876989232
正誤表（2010.4.30）PDF
発行年月: 2010/04
記述言語: 英語
- 本体： 8,000円（税込 8,800円）
-
在庫あり
術前全身療法と外科的局所療法を統合し，最適療法のコンセンサスを目指して――「京都乳癌コンセンサス会議」2009国際大会の成果．外科手術・放射線治療，薬物療法その他の集学的な診療アプローチを俯瞰し，その戦略と手法，留意点，評価法を明快にまとめた．初期乳癌の治療に先端的知見を提供する，臨床医必携の包括的ハンドブック．
"SciTech Book News" September 2010, p.71.
■Editors
Masakazu Toi (Kyoto University, Japan)
Graduated from Faculty of Medicine, Hiroshima University in 1982, he studied abroad to Oxford University, UK in 1990 and Center of Oncology Dana Farber Cancer Institute, Harvard University in 2000. Since he came back to Japan, teaches Professor of DDS center, Tokyo University of Science in 2003. Professor of Department of Breast Surgery Graduate School of Medicine Kyoto University from 2007. Chairperson of Kyoto Breast Cancer Consensus Conference (KBCCC). Board member of Japanese Cancer Association, Japan Society of Clinical Oncology, Japan Surgical Society and The Japanese Breast Cancer Society.
Eric P. Winer (Harvard University, USA)
Dr. Winer received his MD from Yale University in 1983, and later completed training in internal medicine and served as chief resident at Yale-New Haven Hospital. He subsequently was a fellow in hematology-oncology at Duke University Medical Center, and from 1989 to 1997 served on the Duke faculty, where he became co-director of the multidisciplinary breast program. In 1997, he joined Brigham and Women's Hospital and DFCI, where he is director of the Breast Oncology Center. He currently serves as the cancer communication committee chairperson of American Society of Clinical Oncology, the chief scientific advisor / advisory committee chairperson of the Susan G. Komen Breast Cancer Foundation.
Masakazu Toi (Kyoto University, Japan)
Graduated from Faculty of Medicine, Hiroshima University in 1982, he studied abroad to Oxford University, UK in 1990 and Center of Oncology Dana Farber Cancer Institute, Harvard University in 2000. Since he came back to Japan, teaches Professor of DDS center, Tokyo University of Science in 2003. Professor of Department of Breast Surgery Graduate School of Medicine Kyoto University from 2007. Chairperson of Kyoto Breast Cancer Consensus Conference (KBCCC). Board member of Japanese Cancer Association, Japan Society of Clinical Oncology, Japan Surgical Society and The Japanese Breast Cancer Society.
Eric P. Winer (Harvard University, USA)
Dr. Winer received his MD from Yale University in 1983, and later completed training in internal medicine and served as chief resident at Yale-New Haven Hospital. He subsequently was a fellow in hematology-oncology at Duke University Medical Center, and from 1989 to 1997 served on the Duke faculty, where he became co-director of the multidisciplinary breast program. In 1997, he joined Brigham and Women's Hospital and DFCI, where he is director of the Breast Oncology Center. He currently serves as the cancer communication committee chairperson of American Society of Clinical Oncology, the chief scientific advisor / advisory committee chairperson of the Susan G. Komen Breast Cancer Foundation.
Prefaratory Note:
Hiroshi Sonoo (Chairman of the Board of Directors, Japanese Society of Breast Cancer, Professor of Kawasaki Medical University, Japan)
Chapter 1: Overview and Future Perspectives of Primary Breast Cancer
John Forbes (The University of Newcastle, Australia)
Chapter 2: Axillary Diagnosis and Treatment
- Section A. Ultrasound for Axillary Staging
Chiun-Sheng Huang (National Taiwan University, Taiwan)
- Section B. Bio-optical Aspects in Indocyanine Green Fluorescence for Sentinel Node Biopsy in Breast Cancer
Toshiyuki Kitai (Nara Social Insurance Hospital, Japan)
- Section C. Axillary Node Assessment and Treatment after Neo-adjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
Eun Sook Lee (Korea University, Korea)
- Section D. Current Status of Sentinel Node Biopsy for Breast Cancer in Japan
Seigo Nakamura (St. Luke's International Hospital, Japan)
- Section E. Controversy of Axillary Diagnosis and Treatment
Tomoharu Sugie (Kyoto University, Japan)
Chapter 3: Optimal Breast Surgery
- Section A. Optimum Breast Surgery
John Benson (Addenbrooke's Hospital and the University of Cambridge, UK)
- Section B. Local Management of Primary Breast Cancer Optimal Breast Surgery
Nasim Ahmadiyeh and Mehra Golshan (Brigham and Woman's Hospital and Dana Farber Cancer Institute, USA)
- Section C. Optimal Surgery for Breast Cancer
Michail Shafir (The Mount Sinai Hospital, USA)
- Section D. Optimal Breast Surgery: Questionnaire about Optimal Surgery for Breast Cancer at Kyoto Breast Cancer Consensus Conference (KBCCC) in 2009
Takashi Inamoto (Kitano Hospital, Japan)
Chapter 4: Pathology
Histopathologic Prognostic Factors of Early Breast Cancer
Yoshiki Mikami (Kyoto University, Japan) and Hironobu Sasano (Tohoku University, Japan)
Chapter 5: Genetics-personal Genomics Data
Dimitrios Roukos and Dimosthenis Ziogas(Ioannina University, Greece)
Chapter 6: Radiation therapy
- Section A. New Strategies of Radiotherapy in Patients with Early Breast Cancer
Rodrigo Arrigada (Institute Gustave Roussy, France / Karolinska Institutet, Sweden)
- Section B. Postmastectomy Radiotherapy in 'Intermediate-risk' Breast Cancer
Ian Kunkler (The University of Edinburgh, UK)
- Section C. Current Pattern of Care in Radiation Therapy in Korea, China and Japan
Sung Whan Ha (Seoul National University, Korea) , Jiayi Chen (Fudan University, China) and Michihide Mitsumori (Kyoto University, Japan)
- Section D. The Role of Radiation Therapy after Initial Chemotherapy
Eric A. Strom (The University of Texas M.D. Anderson Cancer Center, USA)
Chapter 7: Preoperative Therapy
- Section A. How to Optimize Neoadjuvant Chemotherapy in Breast Cancer Patients? - Experience of the German Breast Group (GBG)
Gunter von Minckwitz (University of Frankfurt, Germany)
- Section B. Local Management after Preoperative Chemotherapy
Raimund Jakesz (University of Vienna, Austria) and Karl Thomanek (University of Vienna, Austria)
- Section C. Local Management after Pre-operative Chemotherapy
Hiroyasu Yamashiro, Masahiro Takada and Masakazu Toi (Kyoto University, Japan)
Section D. Local Management after Pre-operative Anti-HER2 Therapy Nobuko Sakita, Takayuki Ueno and Masakazu Toi (Kyoto University, Japan)
- Section E. Local Management after Pre-operative Hormone Therapy
Hironobu Sasano (Tohoku University, Japan)
Hiroshi Sonoo (Chairman of the Board of Directors, Japanese Society of Breast Cancer, Professor of Kawasaki Medical University, Japan)
Chapter 1: Overview and Future Perspectives of Primary Breast Cancer
John Forbes (The University of Newcastle, Australia)
Chapter 2: Axillary Diagnosis and Treatment
- Section A. Ultrasound for Axillary Staging
Chiun-Sheng Huang (National Taiwan University, Taiwan)
- Section B. Bio-optical Aspects in Indocyanine Green Fluorescence for Sentinel Node Biopsy in Breast Cancer
Toshiyuki Kitai (Nara Social Insurance Hospital, Japan)
- Section C. Axillary Node Assessment and Treatment after Neo-adjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
Eun Sook Lee (Korea University, Korea)
- Section D. Current Status of Sentinel Node Biopsy for Breast Cancer in Japan
Seigo Nakamura (St. Luke's International Hospital, Japan)
- Section E. Controversy of Axillary Diagnosis and Treatment
Tomoharu Sugie (Kyoto University, Japan)
Chapter 3: Optimal Breast Surgery
- Section A. Optimum Breast Surgery
John Benson (Addenbrooke's Hospital and the University of Cambridge, UK)
- Section B. Local Management of Primary Breast Cancer Optimal Breast Surgery
Nasim Ahmadiyeh and Mehra Golshan (Brigham and Woman's Hospital and Dana Farber Cancer Institute, USA)
- Section C. Optimal Surgery for Breast Cancer
Michail Shafir (The Mount Sinai Hospital, USA)
- Section D. Optimal Breast Surgery: Questionnaire about Optimal Surgery for Breast Cancer at Kyoto Breast Cancer Consensus Conference (KBCCC) in 2009
Takashi Inamoto (Kitano Hospital, Japan)
Chapter 4: Pathology
Histopathologic Prognostic Factors of Early Breast Cancer
Yoshiki Mikami (Kyoto University, Japan) and Hironobu Sasano (Tohoku University, Japan)
Chapter 5: Genetics-personal Genomics Data
Dimitrios Roukos and Dimosthenis Ziogas(Ioannina University, Greece)
Chapter 6: Radiation therapy
- Section A. New Strategies of Radiotherapy in Patients with Early Breast Cancer
Rodrigo Arrigada (Institute Gustave Roussy, France / Karolinska Institutet, Sweden)
- Section B. Postmastectomy Radiotherapy in 'Intermediate-risk' Breast Cancer
Ian Kunkler (The University of Edinburgh, UK)
- Section C. Current Pattern of Care in Radiation Therapy in Korea, China and Japan
Sung Whan Ha (Seoul National University, Korea) , Jiayi Chen (Fudan University, China) and Michihide Mitsumori (Kyoto University, Japan)
- Section D. The Role of Radiation Therapy after Initial Chemotherapy
Eric A. Strom (The University of Texas M.D. Anderson Cancer Center, USA)
Chapter 7: Preoperative Therapy
- Section A. How to Optimize Neoadjuvant Chemotherapy in Breast Cancer Patients? - Experience of the German Breast Group (GBG)
Gunter von Minckwitz (University of Frankfurt, Germany)
- Section B. Local Management after Preoperative Chemotherapy
Raimund Jakesz (University of Vienna, Austria) and Karl Thomanek (University of Vienna, Austria)
- Section C. Local Management after Pre-operative Chemotherapy
Hiroyasu Yamashiro, Masahiro Takada and Masakazu Toi (Kyoto University, Japan)
Section D. Local Management after Pre-operative Anti-HER2 Therapy Nobuko Sakita, Takayuki Ueno and Masakazu Toi (Kyoto University, Japan)
- Section E. Local Management after Pre-operative Hormone Therapy
Hironobu Sasano (Tohoku University, Japan)
ご購入方法について
